TCL Archive In Brief: Mansfield To Head NCI Radiation Research; Cowan Is Acting Chief, Medicine Branch June 23, 1995
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment September 27, 2013